InvestSMART

Tissue Repair Ltd (ASX: TRP) - Announcements

- Current share price for TRP : $0.080

ASX company news and announcements for Tissue Repair Ltd (TRP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Tissue Repair Ltd (TRP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Tissue Repair Ltd (TRP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Tissue Repair Ltd (TRP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$5 Takeover Panel Media release & Independent Director changes 25 Sep 2024 5:57PM $0.370 $0.080 fallen by 78.38%
$5 TOV: TRP - President Declines Consent to Review 24 Sep 2024 4:59PM $0.370 $0.080 fallen by 78.38%
$5 Notice of Annual General Meeting/Proxy Form 24 Sep 2024 10:14AM $0.380 $0.080 fallen by 78.95%
$5 TOV: TRP - Panel Accepts Undertaking and Declines to Conduct 20 Sep 2024 4:37PM $0.460 $0.080 fallen by 82.61%
$5 Notification regarding unquoted securities - TRP 19 Sep 2024 10:13AM $0.470 $0.080 fallen by 82.98%
$5 Re- Takeovers Panel - Media Release 2 Sep 2024 2:19PM $0.420 $0.080 fallen by 80.95%
$5 2024 Annual General Meeting Date 30 Aug 2024 5:54PM $0.420 $0.080 fallen by 80.95%
$5 TOV: TRP - Panel Receives Application 29 Aug 2024 4:34PM $0.420 $0.080 fallen by 80.95%
$5 Appendix 4G and Corporate Governance Statement 22 Aug 2024 4:48PM $0.370 $0.080 fallen by 78.38%
$5 Appendix 4E and Annual Report 30 June 2024 22 Aug 2024 4:46PM $0.370 $0.080 fallen by 78.38%
$5 Tony Charara Co-founder appointed as CEO 8 Aug 2024 1:43PM $0.335 $0.080 fallen by 76.12%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 31 Jul 2024 4:06PM $0.365 $0.080 fallen by 78.08%
$5 Company Update - Presentation 31 Jul 2024 3:32PM $0.385 $0.080 fallen by 79.22%
$5 TGA approval granted for Tissue Repair TR Pro 25 Jul 2024 12:06PM $0.230 $0.080 fallen by 65.22%
$5 Application for quotation of securities - TRP 15 May 2024 5:06PM $0.220 $0.080 fallen by 63.64%
$5 Notice under ASX Listing Rule 3.10A 9 May 2024 6:08PM $0.235 $0.080 fallen by 65.96%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 12:54PM $0.240 $0.080 fallen by 66.67%
$5 Notification regarding unquoted securities - TRP 4 Apr 2024 10:41AM $0.230 $0.080 fallen by 65.22%
$5 Change of Company Secretary 1 Mar 2024 9:44AM $0.225 $0.080 fallen by 64.44%
$5 Appendix 4D and Half Year Report to 31 December 2023 29 Feb 2024 8:11AM $0.225 $0.080 fallen by 64.44%
$5 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jan 2024 9:09AM $0.260 $0.080 fallen by 69.23%
$5 Third US Patent granted for Tissue Repair Glucoprime 19 Dec 2023 8:22AM $0.210 $0.080 fallen by 61.90%
$5 Application for quotation of securities - TRP 20 Nov 2023 4:43PM $0.250 $0.080 fallen by 68%
$5 Change of Director's Interest Notice - Michael Silberberg 16 Nov 2023 1:26PM $0.250 $0.080 fallen by 68%
$5 Notification regarding unquoted securities - TRP 15 Nov 2023 1:24PM $0.250 $0.080 fallen by 68%

51 - 75 of 192 results

Page 3 of 8

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.